| Carvedilol Krka 12.5 mg Tablets PA1347/037/003 |
Carvedilol |
KRKA, d.d., Novo mesto |
Marketed |
| Carvedilol Krka 25 mg Tablets PA1347/037/004 |
Carvedilol |
KRKA, d.d., Novo mesto |
Marketed |
| Carvedilol Krka 3.125 mg Tablets PA1347/037/001 |
Carvedilol |
KRKA, d.d., Novo mesto |
Marketed |
| Carvedilol Krka 6.25 mg tablets PA1347/037/002 |
Carvedilol |
KRKA, d.d., Novo mesto |
Marketed |
| CARVYKTI 3.2 × 10^6 – 1 × 10^8 cells dispersion for infusion EU/1/22/1648/001 |
Ciltacabtagene autoleucel |
Janssen Pharmaceutica NV |
— |
| Casacol Expectorant SyrupMethoxyphenamine hydrochloride 20 mg/5 ml Guaiphenesin 100 mg/5 ml Sodium Citrate 200 mg/5 ml PA1113/007/001 |
Methoxyphenamine hydrochloride, Sodium citrate, Guaiphenesin |
Phoenix Labs Unlimited Company |
Marketed |
| Casgevy 4 - 13 × 10^6 cells/mL dispersion for infusion EU/1/23/1787/001 |
Exagamglogene autotemcel |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Casodex 50 mg film-coated tablets PA23154/002/001 |
Bicalutamide |
Laboratoires Juvise Pharmaceuticals |
Marketed |
| Casodex 50 mg film-coated tablets PPA0465/144/001 |
Bicalutamide |
PCO Manufacturing Ltd. |
— |
| Casodex 50 mg film-coated tablets PPA1463/107/001 |
Bicalutamide |
IMED Healthcare Ltd., |
— |
| Caspofungin 50mg powder for concentrate for solution for infusion PA1226/013/001 |
Caspofungin |
Flynn Pharma Limited |
Not marketed |
| Caspofungin 50mg powder for concentrate for solution for infusion PA0281/246/001 |
Caspofungin |
Pinewood Laboratories Limited |
Marketed |
| Caspofungin 50mg powder for concentrate for solution for infusion PA1989/001/001 |
Caspofungin |
Demo S.A. |
Marketed |
| Caspofungin 70mg powder for concentrate for solution for infusion PA1226/013/002 |
Caspofungin |
Flynn Pharma Limited |
Not marketed |
| Caspofungin 70mg powder for concentrate for solution for infusion PA0281/246/002 |
Caspofungin |
Pinewood Laboratories Limited |
Marketed |
| Caspofungin 70mg powder for concentrate for solution for infusion PA1989/001/002 |
Caspofungin |
Demo S.A. |
Marketed |
| Caspofungin Accord EU/1/15/1081/001 |
Caspofungin acetate |
Accord Healthcare S.L.U. |
— |
| Caspofungin Accord EU/1/15/1081/002 |
Caspofungin acetate |
Accord Healthcare S.L.U. |
— |
| Caspofungin Clonmel 50 mg powder for concentrate for solution for infusion PA0126/341/001 |
Caspofungin acetate |
Clonmel Healthcare Ltd |
Marketed |
| Caspofungin Clonmel 70 mg powder for concentrate for solution for infusion PA0126/341/002 |
Caspofungin acetate |
Clonmel Healthcare Ltd |
Marketed |
| Cataflam 50mg Coated Tablets PA0896/004/001 |
Diclofenac potassium |
Novartis Ireland Limited |
Marketed |
| Catapres Ampoules 150 micrograms in 1 ml Solution for Injection PA2256/002/001 |
Clonidine hydrochloride |
Glenwood GmbH |
Marketed |
| Catapres Tablets 100 micrograms PA2256/003/001 |
Clonidine hydrochloride |
Glenwood GmbH |
Marketed |
| Catasart Plus 16mg/12.5mg tablets PA0711/164/001 |
Candesartan cilexetil, Hydrochlorothiazide |
Rowex Limited, |
Marketed |
| Catephen 10 % ointment PA1748/003/001 |
Green tea dry extract |
Kora Corporation Limited trading as Kora Healthcare |
Not marketed |
| Catiolanze 50 micrograms/mL eye drops, emulsion EU/1/23/1763/001-004 |
Latanoprost |
Santen OY |
— |
| Caverject 10 micrograms Powder and Solvent for Solution for Injection PA0822/115/002 |
Alprostadil |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Caverject 20 micrograms Powder and Solvent for Solution for Injection PA0822/115/003 |
Alprostadil |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Cayston 75 mg powder and solvent for nebuliser solution. EU/1/09/543/001 |
Aztreonam |
Gilead Sciences Ireland UC |
— |
| Cefixime 200 mg film-coated tablets PA1335/002/001 |
CEFIXIME TRIHYDRATE |
Orchid Europe Limited |
Not marketed |
| Cefixime Nectar Lifesciences 100 mg/5 ml Powder for Oral Suspension PA22914/001/001 |
Cefixime |
NECLIFE PT UNIPESSOAL LDA |
Not marketed |
| Cefotaxime 1 g powder for solution for injection/infusion PA1122/019/002 |
Cefotaxime |
Noridem Enterprises Limited |
Not marketed |
| Cefotaxime 1g Powder for solution for injection or infusion PA0281/223/002 |
Cefotaxime |
Pinewood Laboratories Ltd |
Marketed |
| Cefotaxime 2 g powder for solution for injection/infusion PA1122/019/003 |
Cefotaxime |
Noridem Enterprises Limited |
Not marketed |
| Cefotaxime 500 mg powder for solution for injection/infusion PA1122/019/001 |
Cefotaxime |
Noridem Enterprises Limited |
Not marketed |
| Cefotaxime 500mg Powder for solution for injection or infusion PA0281/223/001 |
Cefotaxime |
Pinewood Laboratories Ltd |
Not marketed |
| Cefotaxime hameln 1 g powder for solution for injection/infusion PA2237/008/001 |
Cefotaxime sodium |
hameln pharma gmbh |
Not marketed |
| Cefotaxime hameln 2 g powder for solution for injection/infusion PA2237/008/002 |
Cefotaxime sodium |
hameln pharma gmbh |
Not marketed |
| Cefotaxime Reiwa Healthcare 1g powder for solution for injection/infusion PA25363/001/001 |
Cefotaxime |
Reiwa Healthcare S.L. |
Not marketed |
| Ceftal 250mg coated tablets PA0711/101/002 |
Cefuroxime Axetil Crystalline |
Rowex Limited, |
Not marketed |
| Ceftal 500 mg Coated Tablets PA0711/101/003 |
Cefuroxime Axetil Crystalline |
Rowex Limited, |
Not marketed |
| Ceftazidime 1 g powder for solution for injection/infusion PA1217/012/002 |
Ceftazidime |
Hikma Farmacêutica (Portugal) S.A. |
Not marketed |
| Ceftazidime 1g Powder for solution for injection or infusion PA0281/224/001 |
Ceftazidime |
Pinewood Laboratories Ltd |
Marketed |
| Ceftazidime 2 g powder for solution for injection/infusion PA1217/012/003 |
Ceftazidime |
Hikma Farmacêutica (Portugal) S.A. |
Not marketed |
| Ceftazidime 2g Powder for solution for injection or infusion PA0281/224/002 |
Ceftazidime |
Pinewood Laboratories Ltd |
Marketed |
| Ceftazidime 500 mg powder for solution for injection PA1217/012/001 |
Ceftazidime |
Hikma Farmacêutica (Portugal) S.A. |
Not marketed |
| Ceftazidime hameln 1 g powder for solution for injection/infusion PA2237/010/002 |
Ceftazidime pentahydrate |
hameln pharma gmbh |
Not marketed |
| Ceftazidime hameln 2 g powder for solution for injection/infusion PA2237/010/003 |
Ceftazidime pentahydrate |
hameln pharma gmbh |
Not marketed |
| Ceftazidime hameln 500 mg powder for solution for injection PA2237/010/001 |
Ceftazidime pentahydrate |
hameln pharma gmbh |
Not marketed |
| Ceftriaxone 1 g powder for solution for injection/infusion PA2165/017/001 |
Ceftriaxone sodium |
AS Kalceks |
Not marketed |